FDA lifts hold on BioSante vaccine

FDA lifted a clinical hold on GVAX Prostate Cancer vaccine from BioSante Pharmaceuticals Inc. (NASDAQ:BPAX). The company said the hold was lifted after additional data analyses addressed side-effect concerns. BioSante is planning to begin a Phase II trial of the vaccine, but did not disclose a time frame. ...